Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Default Option Nudging Intervention to Improve the Adherence Rates of Cancer Screening in High-risk Population: Randomized Controlled Trial and Intervention Disclosure Analysis

NCT07682220 is registered in ClinicalTrials.gov with Harbin Medical University as lead sponsor.

NCT NCT07682220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07682220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Default Option Nudging Intervention to Improve the Adherence Rates of Cancer Screening in High-risk Population: Randomized Controlled Trial and Intervention Disclosure Analysis
Lead sponsor
Harbin Medical University
Phase
Not applicable
Overall status
Completed
Start date
April 27, 2025
Completion date
June 1, 2025
Enrollment
1,200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early detection of cancer, lung neoplasms, patient compliance, stomach neoplasms